Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Awdurdod
contractio
I.1) Enw a chyfeiriad
NHS Blood and Transplant
North Bristol Park
Filton, Bristol
BS34 7QH
UK
Ffôn: +44 1179217230
E-bost: Jess.Allen@nhsbt.nhs.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: www.nhsbt.nhs.uk
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Frozen, Non-UK Derived Pathogen Reduced Plasma
II.1.2) Prif god CPV
33141570
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
NHSBT requires pathogen reduced plasma which will then be subsequently manufactured into FFP, Single and pooled cryoprecipitate for paediatric and neonatal use, for recipients born on / after 1.1.1996. Those recipients are deemed not to have been exposed to the risk of vCJD in the UK food chain. Plasma is to be sourced from a TPSG approved (based on SaBTOs 2013 recommendations) country outside the UK with vCJD prevalence >2,5 log lower than the UK.
The Contract commenced on the 8.5.2018, the term of this Contract shall expire 2 years from the end of the Set Up Period and Ramp Up Period 1.12.2018 (estimated). The contract is for a period of 2 years with the option to extend for 2 periods of 12 months.
The estimated value given below is based on 4 years.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 13 200 000.00 GBP
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
33141510
II.2.3) Man cyflawni
Cod NUTS:
UK
II.2.4) Disgrifiad o’r caffaeliad
NHSBT requires pathogen reduced plasma which will then be subsequently manufactured into FFP, Single and pooled cryoprecipitate for paediatric and neonatal use, for recipients born on / after 1.1.1996. Those recipients are deemed not to have been exposed to the risk of vCJD in the UK food chain. Plasma is to be sourced from a TPSG approved (based on SaBTOs 2013 recommendations) country outside the UK with vCJD prevalence >2,5 log lower than the UK.
II.2.5) Meini prawf dyfarnu
Price
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn agored
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
Section V: Dyfarnu contract
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
08/05/2018
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
MacoPharma Ltd
London
UK
NUTS: UK
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot: 13 200 000.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
NHS Blood and Transplant
Bristol
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
06/06/2018